Jing Chen

6.1k total citations · 1 hit paper
172 papers, 3.1k citations indexed

About

Jing Chen is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Jing Chen has authored 172 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Oncology, 60 papers in Hematology and 32 papers in Molecular Biology. Recurrent topics in Jing Chen's work include Acute Myeloid Leukemia Research (33 papers), Hematopoietic Stem Cell Transplantation (30 papers) and CAR-T cell therapy research (22 papers). Jing Chen is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), Hematopoietic Stem Cell Transplantation (30 papers) and CAR-T cell therapy research (22 papers). Jing Chen collaborates with scholars based in China, United States and Hong Kong. Jing Chen's co-authors include Janis L. Abkowitz, Sujata Kale, Michael W. Long, He Huang, Xiao‐Jun Huang, Jianmin Wang, Zimin Sun, Dai‐Hong Liu, Qifa Liu and Lan‐Ping Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jing Chen

158 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

2021 150 citations Jing Chen, Ting Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jing Chen China	29	1.1k	971	969	651	382	172	3.1k
Depei Wu China	28	1.6k 1.5×	958 1.0×	948 1.0×	671 1.0×	437 1.1×	219	3.0k
Rami Mahfouz Lebanon	29	1.0k 0.9×	533 0.5×	1.2k 1.2×	457 0.7×	512 1.3×	200	3.5k
Jianmin Wang China	26	1.3k 1.2×	700 0.7×	820 0.8×	415 0.6×	321 0.8×	141	2.7k
Yasushi Takamatsu Japan	27	1.6k 1.5×	1.3k 1.4×	695 0.7×	1.1k 1.7×	191 0.5×	159	3.6k
Yoko Tabe Japan	31	936 0.9×	541 0.6×	1.3k 1.4×	526 0.8×	159 0.4×	165	3.0k
Tadakazu Kondo Japan	31	1.1k 1.0×	1.1k 1.1×	1.0k 1.1×	734 1.1×	293 0.8×	196	3.3k
David P. Curley United States	18	1.0k 1.0×	954 1.0×	2.2k 2.2×	560 0.9×	169 0.4×	24	3.5k
Arjan A. van de Loosdrecht Netherlands	35	2.0k 1.8×	819 0.8×	1.3k 1.3×	1.4k 2.1×	343 0.9×	181	4.4k
Francis Lacombe France	28	952 0.9×	448 0.5×	948 1.0×	418 0.6×	393 1.0×	82	2.4k
Yongping Song China	35	1.3k 1.2×	2.1k 2.2×	1.4k 1.5×	1.5k 2.3×	369 1.0×	231	4.8k

Countries citing papers authored by Jing Chen

Since Specialization

Citations

This map shows the geographic impact of Jing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Chen more than expected).

Fields of papers citing papers by Jing Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Chen. The network helps show where Jing Chen may publish in the future.

Co-authorship network of co-authors of Jing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Chen. A scholar is included among the top collaborators of Jing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Chen. Jing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Xin‐Yun, Ting Mei, Weimin Wang, et al.. (2025). Hydrogel/nano-immunostimulant composite mitigates surgery-exacerbated immunosuppression for durable postsurgical adjuvant treatment of high-propensity lymph node-metastatic tumors. Biomaterials. 325. 123562–123562. 1 indexed citations

Lin, Yu–Chen, Xia Qin, Miao Yan, et al.. (2024). Droplet digital PCR: An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML. British Journal of Haematology. 204(6). 2332–2341.

Chen, Jing, Nerissa P. Denswil, Hendrik J. Niemarkt, et al.. (2024). Impact of mother’s own milk vs. donor human milk on gut microbiota colonization in preterm infants: a systematic review. PubMed. 3(4). 8–8. 2 indexed citations

Wang, Minglin, Shaobo Wu, Yuhan Chen, et al.. (2024). Tumor suppressor BAP1 suppresses disulfidptosis through the regulation of SLC7A11 and NADPH levels. Oncogenesis. 13(1). 31–31. 7 indexed citations

Du, Yu, Fang Li, Manqi Zhang, et al.. (2024). The Emergence of the Potential Therapeutic Targets: Ultrasound-Based Radiomics in the Prediction of Human Epidermal Growth Factor Receptor 2-Low Breast Cancer. Academic Radiology. 31(7). 2674–2683. 7 indexed citations

Yang, Xiaomin, Xiaohang Huang, Jian Zhang, et al.. (2023). Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma. Frontiers in Immunology. 14. 1219872–1219872. 2 indexed citations

Glasser, Chana L. & Jing Chen. (2023). Harnessing the Immune System: Current and Emerging Immunotherapy Strategies for Pediatric Acute Lymphoblastic Leukemia. Biomedicines. 11(7). 1886–1886.

Tang, Yanjing, et al.. (2023). One-Stop No-Edited Allogenic CAR-T Therapy Bridging HSCT to Treat Children with Relapse and Refractory Acute Lymphoblastic Leukemia: A Prospective Clinical Study from a Single Center. Blood. 142(Supplement 1). 3615–3615.

Li, Qian, et al.. (2022). Effects of Oncogene Neuregulin 1 on Breast Cancer Cells. Pakistan Journal of Biological Sciences. 25(4). 345–352.

10.

Liu, Ting, Wenting Hu, Bowen Cui, et al.. (2022). Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification. Nature Communications. 13(1). 1640–1640. 17 indexed citations

11.

Chen, Jing, et al.. (2022). Effect of Clinical Nursing Pathway Intervention Based on Evidence-Based Medicine on Venous Thrombosis in Long-Term Bedridden Patients. Journal of Healthcare Engineering. 2022. 1–6. 7 indexed citations

12.

Qin, Xia, Yiping Zhu, Ming Zhou, et al.. (2021). Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6–7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years. Annals of Hematology. 100(9). 2363–2373. 7 indexed citations

13.

Wang, Tianyi, Mingxuan Feng, Xinyu Wan, et al.. (2021). Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Cell Transplantation. 30. 2139989353–2139989353. 19 indexed citations

14.

Wang, Tianyi, Xinyu Wan, Fan Yang, et al.. (2021). Successful Treatment of TCF3-HLF–positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy. Clinical Lymphoma Myeloma & Leukemia. 21(6). 386–392. 8 indexed citations

15.

Yan, Miao, et al.. (2019). PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center. European Journal of Pediatrics. 179(3). 463–472. 8 indexed citations

16.

Liu, Yang, Lixia Ding, Jianwei Liang, et al.. (2018). Relatively favorable prognosis for MLL‐rearranged childhood acute leukemia with reciprocal translocations. Pediatric Blood & Cancer. 65(10). e27266–e27266. 4 indexed citations

17.

Qiu, Shanshan, et al.. (2018). Factors That Affect Chinese Parents' Willingness to Donate Children's Biospecimens in Pediatric Research. Biopreservation and Biobanking. 16(6). 402–410. 6 indexed citations

18.

Chen, Jing, Donna A. Santillan, Wei Wei, et al.. (2008). Loss of MLL PHD Finger 3 Is Necessary for MLL-ENL–Induced Hematopoietic Stem Cell Immortalization. Cancer Research. 68(15). 6199–6207. 45 indexed citations

19.

Dimri, Manjari, Mayumi Naramura, Lei Duan, et al.. (2007). Modeling Breast Cancer–Associated c-Src and EGFR Overexpression in Human MECs: c-Src and EGFR Cooperatively Promote Aberrant Three-dimensional Acinar Structure and Invasive Behavior. Cancer Research. 67(9). 4164–4172. 65 indexed citations

20.

Chen, Jing, André Larochelle, Simon P. Fricker, et al.. (2006). Mobilization as a preparative regimen for hematopoietic stem cell transplantation. Blood. 107(9). 3764–3771. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact